The FDA has approved two diagnostic devices that allow women to collect vaginal samples themselves for cervical cancer ...

Vaxxinity, which filed to delist from the Nasdaq last month, is choosing radical transparency about the “abusive relationship ...

What a time to be launching a new biotech focused on inflammation and immunology. | Immunology and inflammation-focused drug ...

BioMarin had already announced plans to cut its pipeline in half, but now the company has confirmed that 170 employees are ...

Flatiron Health’s technology for connecting electronic health records and electronic data captures in clinical trials will be ...

In another tough day for biotech employees, Bolt Biotherapeutics and Tenaya Therapeutics both outlined plans to significantly scale back their workforces. | In another tough day for biotech employees, ...

The FDA is recommending that if anyone still has any home COVID tests left from Cue Health, they should throw them away.  | ...

Radyus Research and Dt&CRO, a South Korean preclinical contract research organization, have agreed to share resources in a ...

Verily Life Sciences began to pull back from the many different areas of the healthcare sector in which it once played to better tailor its bets on becoming a more profitable compa | Once known for ...

Novo Nordisk is coming for Roche’s Hemlibra. A phase 3 trial of the Danish drugmaker’s challenger to the blockbuster ...

Sands Capital has raised more than half a billion dollars for a new life science fund, readying a slew of new bets toward ...

AbbVie has inked a new deal with Gilgamesh Pharmaceuticals aimed at developing next-gen therapies for psychiatric disorders.